Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation

Transplantation

Volumn 86, Issue 10, 2008, Pages 1474-1478

  Neff, Robert T ^a   Hurst, Frank P ^a   Falta, Edward M ^a   Bohen, Erin M ^a   Lentine, Krista L ^b   Dharnidharka, Vikas R ^c   Agodoa, Lawrence Y ^d   Jindal, Rahul M ^a,e   Yuan, Christina M ^a   Abbott, Kevin C ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Kidney transplant; Mycophenolate mofetil; Progressive multifocal leukoencephalopathy

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK ASSESSMENT; SURVIVAL RATE; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; IMMUNOLOGY; MEDICARE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES;

ADULT; COHORT STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MEDICARE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES;

EID: 58149334927     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818b62c8     Document Type: Article

References (26)

1. Communication about an ongoing safety review of CellCept (mycophenolate mofetil) and Myfortic (mycophenolate acid). US Food and Drug Administration; April 10, 2008. Available at: http://www.fda.gov/ medwatch/safety/2008/safety08. htm#mycophenolate. Accessed June 7, 2008.
2. 2007USRDS Annual Data Report. Available at: http://www.usrds.org/ atlas.htm. Accessed June 7, 2008.
3. Legtain M, Graveleau J, Brion S, et al. Leucoencephalopathie multifocale progressive après transplantation renale. J Neurol Sci 1974; 23: 49.
4. ZuRhein GM, Varakis J. Progressive multifocal leukoencephalopathy in a renal-allograft recipient. N Engl J Med 1974; 291: 798.
5. McCormick WF, Schochet SS, Sarles HE, et al. Progressive multifocal leukoencephalopathy in renal transplant recipients. Arch Intern Med 1976; 136: 829.
6. Holzhausen HJ, Mampel E, Koall W, et al. Progressive multifocal leukoencephalopathy as a complication of immunosuppression in kidney transplantation. Z Gesamte Inn Med 1977; 32: 578.
7. Selhorst JB, Ducy KF, Thomas JM, et al. PML: Remission and immunologic reversals. Neurology 1978; 28: 337.
8. Egan JD, Ring BL, Reding MJ, et al. Reticulum cell sarcoma and progressive multifocal leukoencephalopathy following renal transplantation. Transplantation 1980; 29: 84.
9. Reznik M, Halleux J, Urbain E, et al. Two cases of progressive multifocal leukoencephalopathy after renal transplantation. Acta Neuropathol Suppl 1981; 7: 189.
10. Saxton CR, Gailiunas P, Halderman JH, et al. Progressive multifocal leukoencephalopathy in a renal transplant recipient. Increased diagnostic sensitivity of computed tomographic scanning by double-dose contrast with delayed films. Am J Med 1984; 77: 333-337.
11. Taborsky P, Hrzbanek J, Jirasek A, et al. Progressive multifocal leukoencephalopathy in a female patient after kidney transplantation. Vnitr Lek 1998; 44: 108.
12. Berner B, Kreiter DH, Rumpf KW, et al. Progressive multifocal leukoencephalopathy in a female transplant patient diagnosed by JCV-specific DNA amplification and an intrathecal humoral immune response to recombinant virus protein 1. Nephrol Dial Transplant 1999; 14: 462.
13. Phillips T, Jacobs R, Ellis EN. Polyoma nephropathy and progressive multifocal leukoencephalopathy in a renal transplant recipient. J Child Neurol 2004; 19: 301.
14. Crowder CD, Gyure KA, Drachenberg CB, et al. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am J Transplant 2005; 5: 1151.
15. Astrom KE, Mancall EL, Richardson EP. Progressive multifocal leukoencephalopathy: A hitherto unrecognized complication of chronic leukaemia and Hodgkin's disease. Brain 1958; 81: 93.
16. Berger JR, Pall L, Lanska D, et al. Progressive multifocal leukoencephalopathy. N Engl J Med 1961; 265: 815.
17. Randhawa PS, Baksh F, Aoki N, et al. JC virus infection in allograft kidneys: Analysisbypolymerase chain reaction and immunochemistry. Transplantation 2001;71: 1300.
18. Boren EJ, Cheema GS, Naguwa SN, et al. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun 2008; 30: 90.
19. Padgett BL, Walker DL, ZuRhein DM, et al. Cultivation of papoka-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971; 1: 1257.
20. Berger JR, Concha M. Progressive multifocal leukoencephalopathy: The evolution of a disease once considered rare. J Neurovirol 1995; 1: 5.
21. Chen Y, Trofe J, Grodon J, et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant patients with polyomavirus nephropathy. J Virol 2006; 80: 3495.
22. KrymskayaL, SharmaMC, Martinez J, et al. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 2005; 79: 11170.
23. SharmaMC, ZhouW, Martinez J, et al. Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals. Virology 2006; 350: 128.
24. Chen Y, Trofe J, Gordon J, et al. BKV and JCV large T antigen-specific CD8(+) T cell response in HLAA*0201(+) kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol 2008; doi:10.1016/j.jcv. 2008.01.005.
25. Abbott KC, Oglesby RJ, Agodoa LY. Hospitalized avascular necrosis after renal transplantation in the United States. Kidney Int 2002; 62:2250.
26. Zivkovic S. Neuroimaging and neurologic complications after organ transplantation. J Neuroimaging 2007; 17: 110.